Navigation Links
MedCath Corporation Reports First Quarter Earnings
Date:2/7/2008

d $0.2 million, or $0.01 per diluted share, in the first quarter of fiscal 2008. MedCath did not incur pre-opening expenses in the first quarter of fiscal 2007. Adjusted EBITDA in this release does not include share-based compensation expense or pre-opening expenses, but these expenses are included as a component of income from continuing operations.

"We experienced a strong start to fiscal 2008, driven by strategic and operating initiatives upon which we embarked two years ago and that are the foundation for our successes in this and previous quarters," said O. Edwin French, MedCath's president and chief executive officer. "Our hospitals had strong inpatient and outpatient volumes, and our operating initiatives allowed us to expand our Adjusted EBITDA and increase our EPS during the quarter."

Operating Statistics and Cash Flow

Same facility hospital adjusted admissions for the first quarter of fiscal 2008 increased 6.4% from the first quarter of the previous fiscal year. Same facility hospital net revenue increased 4.6% after adjusting first quarter of 2007's revenue for a reimbursement adjustment that reduced net revenue by $2.7 million. Net cash provided by operating activities of continuing operations for the first quarter of fiscal 2008 was $0.7 million, down from $11.4 million for the first quarter of fiscal 2007. This decrease was due to the payment of a previously announced $5.8 million settlement between one of MedCath's hospitals and the United States Department of Justice and a $9.2 million increase in cash tax payments during the first quarter of fiscal 2008 in comparison to the first quarter of fiscal 2007.

Capital expenditures, including $4.6 million in expenditures related to MedCath's growth initiatives, totaled $14.3 million in the first quarter of fiscal 2008 in comparison to $3.5 million in the first quarter of fiscal 2007.

Use of Non-GAAP Financial Measures

This release contains measures of MedCath's hist
'/>"/>

SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. MedCath Corporation to Hold Conference Call on First Quarter Results
2. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
3. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
4. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
5. Otter Tail Corporation Reports Record Revenues and Net Income From Continuing Operations for 2007; Earnings Per Share of $1.78; Board Approves Dividend Increase
6. STERIS Corporation Promotes Timothy L. Chapman to Group President of Healthcare
7. Volcano Corporation Selects Xactly to Drive Strategic Sales Performance Management
8. CRH Medical Corporation announces substantial increase in patient visits
9. Medical Simulation Corporation and the American Board of Internal Medicine Introduce New Simulation for Physician Assessment and Evaluation
10. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
11. Triple-S Management Corporation to Present at UBS Global Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...reatment advances, study finds , , MONDA... of saliva changes as people age, and better under...e test to diagnose and treat age-related diseases,...umerous proteins that play a role in digestion, fi...re trying to find ways to use these proteins to de...
(Date:11/23/2009)...le age are more than twice as likely to develop de...om the Sahlgrenska Academy. , The study has just...gy . , "Anyone carrying a lot of fat around the ... to a heart attack or stroke," says Deborah Gustaf...If they nevertheless manage to live beyond 70, the...
(Date:11/23/2009)...gia is leading an initiative that could result in ...le cell disease. , Morehouse University School ... in the initiative that is enlisting primary care ...es" for patients, changing how patients are treate...d seeking better prevention and treatment strategi...
(Date:11/23/2009)...ed Strategic Communications Agency Honored by Asso...ls , Salem, MA (PRWEB) No...cused strategic communications agency, announced t...rd in the design/website homepage category adminis...nd Communication Professionals. The MarCom 2009 Aw...
(Date:11/23/2009)...--AnnTaylorStoresCorp.announcedtodaythatitwillretu...ivingcampaign,aholidayfundraisingandawarenessprogr...ksthethirdyearthatAnnTaylor,throughitsANNCARESchar...nwhereweofferourshoppersanopportunitytohelpsavechi...lidayseason.ClientswhoshopatAnnTaylor,Loft,AnnTayl...
Breaking Medicine News(10 mins):Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2
...st cancer and inflammatory breast cancer , ...are overweight or obese when diagnosed with locall...ecurrence and a shorter life expectancy than eithe...derweight patients to be diagnosed with a rare, ag...
...esident and Chief Executive Officer,American Lung ... The American Lung,Association salutes the new U.... substantial cuts in the air pollution produced by...lution.,Cleaning up diesel locomotives and marine ...
...ort:, COLORADO SPRINGS, Colo., March 14 Sedentar...ity of life by exercising,as little as 10 to 30 mi...Heart Association,s Conference on Nutrition, Physi...controlled trial,examining the role of exercise in...
...s in developing countries , , FRIDAY, Mar...ing a person,s cardiovascular disease risk, cheap,...ve as lab tests, a new study finds. , The U.S. res...orldwide, about 80 percent of cardiovascular death...
...s in the laboratory suggests that a new compound c... in people infected with the latent form of the ba...ornell Medical College in New York City. A drug wi...o points to new ways of thinking about fighting ba...
...Redondo,Beach, California, had no idea that she wo...s and stop the production of one of the deadliest,...-- asbestos. Reinstein is,executive director and c...asbestos victims and their families., On Saturday...
Other Medicine News:Health News:Obesity Linked to Poor Prognosis for Some Breast Cancer Patients 2Health News:Obesity Linked to Poor Prognosis for Some Breast Cancer Patients 3Health News:Locomotive and Marine Diesel Engines Clean Up Will Save Lives 2Health News:Overweight, Obese Women Improve Quality of Life With 10 to 30 Minutes of Exercise 2Health News:Overweight, Obese Women Improve Quality of Life With 10 to 30 Minutes of Exercise 3Health News:Overweight, Obese Women Improve Quality of Life With 10 to 30 Minutes of Exercise 4Health News:Heart Risk Can Be Predicted Without Lab Tests 2Health News:New chemical can kill latent tuberculosis bacteria 2Health News:New chemical can kill latent tuberculosis bacteria 3Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 2Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 3Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 4Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 5Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 6
(Date:11/23/2009)...ewswire/--AMDLASERSannouncedthisweekthatitcontinue...ingwithprestigiousindustry-leaderDr.LarryRosenthal...eexclusivesofttissuediodelaserusedduringallinterna...op2%ofdentists. ,, (Photo: http://www.newscom.c...greatpleasurethatIproudlyannounceourpartnership.So...
(Date:11/23/2009)...Newswire-FirstCall/--RaptorPharmaceuticalCorp.("Ra...resultsfromaPhase2bclinicaltrialofitsproprietaryde...npatientswithnephropathiccystinosis("cystinosis")....iego("UCSD")GeneralClinicalResearchCenter,evaluate...namicsofasingledoseofDRCysteamineinninecystinosisp...
(Date:11/23/2009)...v.23 /PRNewswire/-- LaerdalMedical,inalliancewit...secondvolumeofpre-programmedscenariosforusewithLae...sdesignedtointegratesimulationintotheAAP,sNeonatal...tmentofothercriticalmedicalconditionsintheneonatal...n/prnh/20091123/NY14903LOGO ) ,, (Logo: http://...
Breaking Medicine Technology:AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Neonatal Scenarios Developed in Partnership with the American Academy of Pediatrics (AAP), Utilize the NRP Curriculum to Advance Newborn Care 2New Jersey Hospital to Pay 243 Million to Resolve Allegations of Medicare Fraud 61648 1New Jersey Hospital to Pay 243 Million to Resolve Allegations of Medicare Fraud 61648 2Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 1Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 2Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 3Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 4Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 5Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 6Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 7Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 8Delcath Systems Announces Completion of Public Offering 6385 1Delcath Systems Announces Completion of Public Offering 6385 2
.... 21 FASgen is pleased to report the,publication ...ield using,FAS89B, one of the Company,s proprietar...search into selective inhibition of fatty acid syn... in the area of metabolic,disease disorders, speci...er disease. The Company has a long-standing cooper...
..., Dec. 20 Novavax, Inc.,(Nasdaq: NVAX ) announce...Ia,human clinical trial of its non-adjuvanted pand...andidate., Penny Heaton, MD, Chief Medical Office...itial results from our Phase I/IIa study are,promi...ic influenza vaccine,through regulatory licensure....
Other Medicine Technology:FASgen Announces a New Discovery in Obesity Research 2Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program 4
...tient Comfort than chest tubes and Enhanced Ambula...cone drains with four channels along the sides wit...ist of a silicone hub, a silicone extension tubing.../4 fluted (hub outside skin) or full fluted (hub i...
Laparoscopic Introducer Set
Fanelli Laparoscopic Endobiliary Stent Set
Common Duct Exploration Set: With N-Circle® Nitinol Tipless Stone Extractor
Medicine Products: